SEC Form 4 · accession 0001203311-18-000010
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel G Welch
Director
Period of report
Feb 13, 2018
Accepted (ET)
Feb 15, 2018 · 9:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 13, 2018 | M | 10,000 | $10.08 | A | 59,219 | D | |
| Common StockF1 | Feb 13, 2018 | M | 6,881 | $8.38 | A | 66,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $8.38 | Feb 13, 2018 | M | 6,881 | D | — | May 15, 2019 | Common Stock | 6,881 | 0 | D |
| Non-Qualified Stock Option (right to buy)F3 | $10.08 | Feb 13, 2018 | M | 10,000 | D | — | May 16, 2018 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F2Shares vested in full on May 14, 2010.
- F3Shares vested in full on May 15, 2009.